This browser is no longer supported

Please switch to a supported browser to continue using this website.
Consider using the latest version of Google Chrome or Microsoft's Edge to view this website.

Global Selector Contact Partnering Newsroom
Investors

CSL's 2024 R&D Investor Briefing

CSL's 2024 R&D Investor Briefing Webcast will be live from 9am on Tuesday, 22nd October 2024 (AEDT).

To pre-register for the webcast, please visit this link.

View our 2024 Annual report

COVID-19: A Message from Our CEO

"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited

ASX ANNOUNCEMENTS

View All Investor Announcements

SHARE PRICE

CSL Mkt Cap:
The Market is currently
Price Delay ~20min
Read More

FINANCIAL RESULTS

View All Results

Annual General Meeting (AGM) Information

CSL's 2024 AGM will be held on Tuesday, 29th October at 10am (AEDT).

Learn More
Cover Image of CSL's 2023 Annual Report

View our annual report 2024
Subscribe to our ASX Announcements
 
Privacy Notice

Introduction to CSL

See how we are driven by our promise.

Learn More

Board and Management

View our Board and Management here.

Learn More

Corporate Governance

View our corporate governance here.

Learn More
Terms of Use Cookie Policy Privacy Policy Accessibility Statement Sitemap
© CSL, All Rights Reserved